These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 31841593)

  • 1. Impact of Changes in Detection Effort on Control of Visceral Leishmaniasis in the Indian Subcontinent.
    Coffeng LE; Le Rutte EA; Muñoz J; Adams ER; Prada JM; de Vlas SJ; Medley GF
    J Infect Dis; 2020 Jun; 221(Suppl 5):S546-S553. PubMed ID: 31841593
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Elimination of visceral leishmaniasis in the Indian subcontinent: a comparison of predictions from three transmission models.
    Le Rutte EA; Chapman LAC; Coffeng LE; Jervis S; Hasker EC; Dwivedi S; Karthick M; Das A; Mahapatra T; Chaudhuri I; Boelaert MC; Medley GF; Srikantiah S; Hollingsworth TD; de Vlas SJ
    Epidemics; 2017 Mar; 18():67-80. PubMed ID: 28279458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Policy Recommendations From Transmission Modeling for the Elimination of Visceral Leishmaniasis in the Indian Subcontinent.
    Le Rutte EA; Chapman LAC; Coffeng LE; Ruiz-Postigo JA; Olliaro PL; Adams ER; Hasker EC; Boelaert MC; Hollingsworth TD; Medley GF; de Vlas SJ
    Clin Infect Dis; 2018 Jun; 66(suppl_4):S301-S308. PubMed ID: 29860292
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Feasibility of eliminating visceral leishmaniasis from the Indian subcontinent: explorations with a set of deterministic age-structured transmission models.
    Le Rutte EA; Coffeng LE; Bontje DM; Hasker EC; Postigo JA; Argaw D; Boelaert MC; De Vlas SJ
    Parasit Vectors; 2016 Jan; 9():24. PubMed ID: 26787302
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Visceral leishmaniasis elimination targets in India, strategies for preventing resurgence.
    Sundar S; Singh OP; Chakravarty J
    Expert Rev Anti Infect Ther; 2018 Nov; 16(11):805-812. PubMed ID: 30289007
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The potential impact of human visceral leishmaniasis vaccines on population incidence.
    Le Rutte EA; Coffeng LE; Malvolti S; Kaye PM; de Vlas SJ
    PLoS Negl Trop Dis; 2020 Jul; 14(7):e0008468. PubMed ID: 32614857
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inferring transmission trees to guide targeting of interventions against visceral leishmaniasis and post-kala-azar dermal leishmaniasis.
    Chapman LAC; Spencer SEF; Pollington TM; Jewell CP; Mondal D; Alvar J; Hollingsworth TD; Cameron MM; Bern C; Medley GF
    Proc Natl Acad Sci U S A; 2020 Oct; 117(41):25742-25750. PubMed ID: 32973088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Towards elimination of visceral leishmaniasis in the Indian subcontinent-Translating research to practice to public health.
    Hirve S; Kroeger A; Matlashewski G; Mondal D; Banjara MR; Das P; Be-Nazir A; Arana B; Olliaro P
    PLoS Negl Trop Dis; 2017 Oct; 11(10):e0005889. PubMed ID: 29023446
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Visceral leishmaniasis: Spatiotemporal heterogeneity and drivers underlying the hotspots in Muzaffarpur, Bihar, India.
    Bulstra CA; Le Rutte EA; Malaviya P; Hasker EC; Coffeng LE; Picado A; Singh OP; Boelaert MC; de Vlas SJ; Sundar S
    PLoS Negl Trop Dis; 2018 Dec; 12(12):e0006888. PubMed ID: 30521529
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effectiveness and feasibility of active and passive case detection in the visceral leishmaniasis elimination initiative in India, Bangladesh, and Nepal.
    Hirve S; Singh SP; Kumar N; Banjara MR; Das P; Sundar S; Rijal S; Joshi A; Kroeger A; Varghese B; Thakur CP; Huda MM; Mondal D
    Am J Trop Med Hyg; 2010 Sep; 83(3):507-11. PubMed ID: 20810811
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Costs and outcomes of active and passive case detection for visceral leishmaniasis (Kala-Azar) to inform elimination strategies in Bihar, India.
    Dial NJ; Medley GF; Croft SL; Mahapatra T; Priyamvada K; Sinha B; Palmer L; Terris-Prestholt F
    PLoS Negl Trop Dis; 2021 Feb; 15(2):e0009129. PubMed ID: 33534836
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Elimination of visceral leishmaniasis in Nepal: pipe-dreams and possibilities.
    Joshi AB; Banjara MR; Pokhrel S; Jimba M; Singhasivanon P; Ashford RW
    Kathmandu Univ Med J (KUMJ); 2006; 4(4):488-96. PubMed ID: 18603960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Development of Leishmania vaccines in the era of visceral leishmaniasis elimination.
    Engwerda CR; Matlashewski G
    Trans R Soc Trop Med Hyg; 2015 Jul; 109(7):423-4. PubMed ID: 26048873
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trends in spatio-temporal dynamics of visceral leishmaniasis cases in a highly-endemic focus of Bihar, India: an investigation based on GIS tools.
    Mandal R; Kesari S; Kumar V; Das P
    Parasit Vectors; 2018 Apr; 11(1):220. PubMed ID: 29609627
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Will visceral leishmaniasis be eliminated from Nepal? A review of recent (1994-2006) control efforts.
    Bhandari GP; Angdembe MR; Rijal S; Boelaert M
    Nepal Med Coll J; 2011 Sep; 13(3):220-5. PubMed ID: 22808821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Insights from mathematical modelling and quantitative analysis on the proposed WHO 2030 targets for visceral leishmaniasis on the Indian subcontinent.
    NTD Modelling Consortium Visceral Leishmaniasis Group
    Gates Open Res; 2019; 3():1651. PubMed ID: 32803128
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Modelling the impact of COVID-19-related programme interruptions on visceral leishmaniasis in India.
    Le Rutte EA; Coffeng LE; Muñoz J; de Vlas SJ
    Trans R Soc Trop Med Hyg; 2021 Mar; 115(3):229-235. PubMed ID: 33580952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimizing Village-Level Targeting of Active Case Detection to Support Visceral Leishmaniasis Elimination in India.
    Bindroo J; Priyamvada K; Chapman LAC; Mahapatra T; Sinha B; Banerjee I; Mishra PK; Rooj B; Kundan K; Roy N; Gill NK; Hightower A; Sharma MP; Dhingra N; Bern C; Srikantiah S
    Front Cell Infect Microbiol; 2021; 11():648847. PubMed ID: 33842395
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Health-seeking behaviour, diagnostics and transmission dynamics in the control of visceral leishmaniasis in the Indian subcontinent.
    Medley GF; Hollingsworth TD; Olliaro PL; Adams ER
    Nature; 2015 Dec; 528(7580):S102-8. PubMed ID: 26633763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uniting mathematics and biology for control of visceral leishmaniasis.
    Rock KS; le Rutte EA; de Vlas SJ; Adams ER; Medley GF; Hollingsworth TD
    Trends Parasitol; 2015 Jun; 31(6):251-9. PubMed ID: 25913079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.